Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of receptor antagonists and kinase inhibitors. It serves as a building block in medicinal chemistry for designing drugs targeting neurological disorders and inflammatory conditions. Its structure allows for selective modification to enhance binding affinity and pharmacokinetic properties in drug candidates. Also employed in research settings to study structure-activity relationships in quinoxaline-based bioactive molecules.